Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

AHSZX vs QAAGZX overlap: 34% of top holdings shared

Bottom line

How much do AHSZX and QAAGZX overlap?

34% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 31.3% of AHSZX's assets and 40.4% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 55), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

AHSZXQAAGZX
Weight overlap (top 25)34%
Shared holdings10
Weight in shared holdings31.3%40.4%
Total positions55277
Expense ratio0.76%0.86%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings AHSZX and QAAGZX have in common

Holding% of AHSZX% of QAAGZXOverlap
Merck & Company Inc MRK4.18%4.00%4.00%
Johnson & Johnson JNJ4.06%6.64%4.06%
Thermo Fisher Scientific Inc TMO4.00%2.53%2.53%
Cvs Health Corp CVS3.67%0.93%0.93%
Unitedhealth Group Inc UNH3.61%5.88%3.61%
Eli Lilly & Company LLY3.29%14.06%3.29%
Abbott Laboratories ABT2.93%1.91%1.91%
Royalty Pharma Plc RPRX1.94%0.97%0.97%
Guardant Health Inc GH1.81%1.22%1.22%
Vertex Pharmaceuticals Inc VRTX1.80%2.26%1.80%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in AHSZX

  1. Dreyfus Treasury Obligations Cash Management — 6.51%
  2. Impulse Dynamics Ireland — 4.27%
  3. Welltower Inc — 4.12%
  4. Bruker Corp — 3.98%
  5. Illumina Inc — 3.95%
  6. Teva Pharmaceutical Industries Ltd — 3.53%
  7. 10x Genomics Inc — 2.26%
  8. Novo Nordisk A/s — 2.24%
  9. Repligen Corp — 2.21%
  10. Centene Corp — 1.91%
  11. Incyte Corp — 1.86%
  12. Pennant Group Inc (the) — 1.83%
  13. Arrowhead Pharmaceuticals Inc — 1.81%
  14. Corteva Inc — 1.65%
  15. Abivax Sa — 1.61%

Only in QAAGZX

  1. Abbvie Inc — 5.12%
  2. Gilead Sciences Inc — 2.79%
  3. Bristol-myers Squibb Co — 2.12%
  4. Intuitive Surgical Inc — 1.89%
  5. Amgen Inc — 1.80%
  6. Stryker Corp — 1.78%
  7. Elevance Health Inc — 1.54%
  8. Danaher Corp — 1.44%
  9. Natera Inc — 1.44%
  10. Cardinal Health Inc — 1.04%
  11. Tenet Healthcare Corp — 0.94%
  12. Kymera Therapeutics Inc — 0.89%
  13. T. Rowe Price Government Reserve Fund — 0.87%
  14. Protagonist Therapeutics Inc — 0.85%
  15. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeAHSZXQAAGZX
Stocks91.9%96.9%
Cash & short-term funds6.5%0.9%
Preferred stock—2.2%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryAHSZXQAAGZX
US87.0%92.3%
IL3.5%0.2%
DK2.2%0.7%
GB1.9%1.8%
FR1.6%0.3%
CH1.3%0.5%
NL—1.0%
BM0.9%0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do AHSZX and QAAGZX overlap?
About 34% by weight. 10 securities appear in both funds' top 25 holdings; they make up 31.3% of AHSZX's assets and 40.4% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do AHSZX and QAAGZX have in common?
The largest shared holdings are Johnson & Johnson, Merck & Company Inc, Unitedhealth Group Inc, Eli Lilly & Company, Thermo Fisher Scientific Inc.
Should I own both AHSZX and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, AHSZX or QAAGZX?
QAAGZX is broader, with 277 positions versus 55 for AHSZX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.